5Sabena U, Lucy CF, John DC. Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens [ J]. Vaccine ,2007,25 (47) :7984 - 7993.
6Moldoveanu Z, Love-Human L, Huang WQ,et al. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus[ J]. Vaccine, 1998,16 (11-12) : 1216 - 1224.
7McCluskie MJ,Weeratna RD,Krieg AM,et al. CpG DNA is an effective oral adjuvant to protein antigens in mice [ J ]. Vaccine, 2000,19(7-8) :950-957.
8Alignani D, Maletto B, Liscovsky M, et al. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice [ J ]. J LeukocBiol, 2005,77 (6) :898 -905.
9Raghavan S, Nystrem J, Fredriksson M, et al. Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacterpylori infection[J]. Infect Immun ,2003,71 ( 12 ) :7014 - 7022.
10Zuercher AW, Coffin SE, Thurnheer MC,et al. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses in mice [ J ]. Immunobiology,2006,211 (1-2) :11 -27.
